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Molecular Regulation of SCN1A Splicing, by
Heinzen et al. (p. 876)
There is evidence that response to certain antiepileptic
drugs may be inﬂuenced by a splice-site variant in SCN1A.
Patients with the AA genotype at this site have been shown
to require a higher dose for the drug to be effective. A link
between this genotype and the functional consequences
has been suggested by data showing that the alternative
splicing induced by this SNP increases the amount of the
neonatal transcript produced. In such a scenario, those
patients with the AA genotype would have a higher ratio
of neonatal-to-adult transcript than do those with fewer
copies of the polymorphism. In addition to modifying a
consensus splice site, the SNP may also modify a putative
binding site for the splice-modiﬁer protein Nova2. Hein-
zen et al. evaluated how the variant might inﬂuence the
response to antiepileptic drugs. After conﬁrming that the
AA variant does cause lower levels of the neonatal tran-
script, Heinzen et al. then demonstrated that an increase
in Nova2 was able to alter the transcript ratio, so that it
was similar to that present in cells with the GG genotype.
The authors hypothesized that such elucidation of the
splicing control of the SCN1A transcripts would contribute
to future endeavors to improve epilepsy therapy.
Y Chromosomes across the Himalayas, by Gayden
et al. (p. 884)
Geographically, the Tibetan plateau is bounded by the
Kunlun Mountains on the north, the Karakoram range on
the west, and the Himalayas on the south. It has been
speculated that such geographic barriers would lead to
genetic isolation, and previous work has focused on the
historic origins of the populations in the region. Results
have been a source of signiﬁcant controversy, since con-
ﬂicting data have suggested various routes of dispersal.
Gayden et al. sought to shed light on the situation with
an analysis of Y-chromosome haplogroup diversity in the
region. Their goal was not only to learn more about the
genetic structure of the populations involved but also to
evaluate the role the Himalayas have played in restricting
the gene ﬂow into and out of the Tibetan plateau. The
authors found evidence that, although the Himalayas seem
to have restricted movement from the south into Tibet,
gene ﬂow appears to have occurred in the opposite direc-
tion: out of the Tibetan plateau. The directionality of the
barrier is hypothesized to be due to the inability of those
from lower altitudes to effectively cope with the strenuous
conditions associated with living at higher elevations.
FA-D2 Phenotype and FANCD2 Mutations, by Kalb
et al. (p. 895)
Patients with Fanconia anemia (FA) are predisposed to the
development of malignancies and bone-marrow failure.
Several of the proteins in which mutations are known to
cause FA assemble into a “core complex” that is required
for the proper ubiquination of FANCD2. Although the
function of FANCD2 is incompletely understood, it is
thought that the protein is involved in the cellular re-
sponse to DNA damage. The importance of the gene is
highlighted by the severe phenotype of Facd2-deﬁcient
mice, but few human patients with FACD2 have been
studied. Kalb et al. assembled a data set of 29 patients with
FACD2, to analyze the molecular basis of the disease in
each and to search for genotype-phenotype correlations.
One signiﬁcant ﬁnding was the presence of congenital
abnormalities in all studied patients, which is in contrast
to the expectation that 30% of patients with FA will not
present with such phenotypes. Also, as has been observed
in other types of FA, reverse mosaicism was seen in the
hematopoietic system of a fraction of the patients with
FACD2. Of particular note, all patients, including the large
proportion in whom reversion was not identiﬁed, pro-
duced residual levels of protein. This suggested that the
complete absence of the FACD2 protein was lethal and
was in concordance with the phenotype observed in the
knockout mice.
Simple Correction for Stratiﬁcation, by Epstein et
al. (p. 921)
Allele-frequency differences between two populations can
be misinterpreted as signiﬁcant differences in disease-caus-
ing variants. The presence of this population stratiﬁcation
can signiﬁcantly confound results in case-control associa-
tion studies. Current methods of avoiding spurious positive
associations include use of homogeneous populations and/
or correction for allele-frequency heterogeneity through
statistical manipulation of data gathered from panels of
population markers. But there remains evidence that sug-
gests that such statistical methods are not yet able to always
remove the effects of population stratiﬁcation. Epstein et
al. worked to develop a new approach that, by incorporat-
ing a stratiﬁcation score into the testing, allowed them to
accurately detect an association, even in the presence of
population structure. The power of this computationally
simple method was demonstrated through an application
to simulated data, as well as to data from the classic strat-
iﬁcation example of the association between height and
the LCT locus.
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TCF4 Mutations in Pitt-Hopkins Syndrome, by
Amiel et al. (p. 988)
TCF4 Mutations Cause Pitt-Hopkins Syndrome, by
Zweier et al. (p. 994)
Pitt-Hopkins syndrome (PHS) is a severe psychomotor dis-
order characterized by epileptic encephalopathy and ep-
isodes of hyperventilation. Although it was previously sus-
pected that PHS was an autosomal dominant disease, the
genetic etiology of the disease was unknown. Here, two
different groups have used the detection of copy-number
differences to identify candidate regions, the loss of which
causes PHS. In the report, by Amiel et al., the authors used
a BAC array to screen four patients and found that one
had a de novo microdeletion that encompassed 11 genes.
Sequencing of two of these genes in each of the remaining
patients identiﬁed amissensemutation inTCF4. Similarly,
Zweier et al. used SNP arrays to screen two patients with
PHS and found that one had a deletion that contained
three known genes, including TCF4. Further sequence
analysis identiﬁed ﬁve more patients, each of whom had
a mutation in TCF4. Further functional work with lucif-
erase assays supported the hypothesis that the subsequent
mutant proteins were unable to function in the same way
as did the wild-type protein.
This Month on the Cover
Chediak-Higashi syndrome (CHS) and Griscelli syndrome
(GS) are two types of syndromic albinism. Although the
name for CHS credits Chediak with the ﬁrst discovery of
a case of CHS in 1952 (Rev Hematol 7:362–367) and Hi-
gashi for similar ﬁndings in 1954 (Tohoku J Exptl Med 59:
315–332), the ﬁrst description was actually by Beguez-
Cesar in 1943 (Bol Soc Cubana Pediat 15:900–922). Gris-
celli et al. later deﬁned the independent syndrome, GS,
in 1978 (Am J Med 65:691–702). Mutations in the CHS1
gene LYST were identiﬁed in 1996 by Nagle et al. (Nat
Genet 14:307–311). The genes MYO5A and RAB27A are
each associated with a type of GS (Nat Genet 16:289–292;
Nat Genet 25:173–176). Each disease is caused by defects
in melanosome transport. One way to properly distin-
guish CHS from GS is to analyze patient hair with light
microscopy. The differences in the size and distribution
of the melanin granules in these diseases can be appre-
ciated in the images on the cover. From left to right are
a hair from an unaffected individual and a hair each from
individuals with CHS6, CHS4, and GS. Special thanks to
Heidi M. Dorward of the Section on Human Biochemical
Genetics, Medical Genetics Branch, National Human Ge-
nome Research Institute, National Institutes of Health, for
the image.
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